Sioud Mouldy
Division of Cancer Medicine, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Methods Mol Biol. 2025;2965:39-56. doi: 10.1007/978-1-0716-4742-4_2.
RNA sensing by the immune system is a critical mechanism through which cells detect and respond to viral infections and other pathogenic threats. This process involves specialized receptors known as pattern recognition receptors (PRRs), such as Toll-like receptors and RIG-I-like receptors, which recognize distinct RNA structures or motifs associated with pathogens. Upon detection, these receptors activate signaling pathways that lead to the production of type I interferons and other cytokines, orchestrating an antiviral response. Exogenously delivered therapeutic RNAs, including small interfering RNAs and messenger RNAs, can unintentionally trigger innate immune responses by being recognized as foreign by PRRs. This can lead to inflammation or unintended immune responses that could reduce the efficacy of the therapy, by triggering therapeutic mRNA degradation and inhibition of translation. This review describes various RNA-sensing receptors and strategies to mitigate the immunogenicity of exogenously delivered RNAs.
免疫系统对RNA的感知是细胞检测和应对病毒感染及其他致病威胁的关键机制。这一过程涉及被称为模式识别受体(PRR)的特殊受体,如Toll样受体和RIG-I样受体,它们识别与病原体相关的不同RNA结构或基序。一旦检测到,这些受体就会激活信号通路,导致I型干扰素和其他细胞因子的产生,从而协调抗病毒反应。外源性递送的治疗性RNA,包括小干扰RNA和信使RNA,可能会被PRR识别为外来物,从而意外触发先天免疫反应。这可能会导致炎症或意外的免疫反应,通过触发治疗性mRNA降解和抑制翻译来降低治疗效果。本文综述了各种RNA感知受体以及减轻外源性递送RNA免疫原性的策略。